Biologics manufacturing facility expansion
Key Statistics
Client
Janssen Sciences
PM Group Office
Ireland
Cost
€300m

Janssen Sciences Ireland UC (formerly Centocor) is part of the Johnson & Johnson Group. This award-winning development involved a greenfield biomedicines manufacturing facility in Cork, Ireland. The facility produces monoclonal antibody products for the detection and treatment of many human diseases. It will also produce material for clinical trials.

Do you have a pharmaceutical project? Talk to one of our experts.

Andy Rayner
Andy Rayner

Pharmaceutical Sector Director

The project

PM Group and our selected partner designed and delivered this €300m facility located on a 100 acre site. The facility incorporates perfusion cell culture and purification processes. It has a process development centre to facilitate the transfer of technology and provide for the development of new production processes coming through clinical trial stages. The plant has a large scale biologics API production capacity.

Working with the community

Janssen has a long history of supporting the local community in Ringaskiddy and Little Island. The company is committed to maintaining this collaboration into the future. One of Janssen’s priorities is to be a ‘good neighbour’ by remaining in constant contact with the local community.

Our project team worked closely with local residents to mitigate the impact of this large complex project on the community. The project provided traffic mitigation alternatives, used advanced membrane waste water treatment, captured rainwater for recycling, and installed a biomass (wood chip) boiler for base steam load. This project also involved extensive landscaping that included planting 70,000 trees to mitigate visual impact and air quality.

Leading with sustainability and safety

The facility is 40% more energy-efficient than internal benchmark biotech facilities and there was a 90% reduction in the carbon footprint versus fossil fuel. In addition, through careful preparation, communication and implementation of safety planning, this facility is one of the safest, large projects ever built in Ireland.

Andy Rayner

Pharmaceutical Sector Director